News Allis.health – a digital health analyst in your pocket After the breakneck pace of development in the digital health category during the pandemic, 2023 looks like it could be a pivotal year, with financing levels falling and t
Digital Partner Content Research2Guidance launches Allis.Health, a new digital healt... (Berlin, Germany and Salerno, Italy) - On September 18th, 2023, Allis.Health, a new digital health analyst platform, offi
News Just how radical is the FDA's complete response letter move? The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face